We are live on ! Find out more
BC

Broadwater Capital Portfolio holdings

AUM $138M
1-Year Est. Return 28.86%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+28.86%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$129B
AUM Growth
+$128B
Cap. Flow
+$28B
Cap. Flow %
21.75%
Top 10 Hldgs %
47.53%
Holding
227
New
2
Increased
217
Reduced
Closed
7

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$7.36B
2
AAPL icon
Apple
AAPL
+$1.95B
3
MCD icon
McDonald's
MCD
+$1.84B
4
ISRG icon
Intuitive Surgical
ISRG
+$1.64B
5
SYK icon
Stryker
SYK
+$954M

Sector Composition

Rank Sector Weight
1 Technology 29.39%
2 Healthcare 15.15%
3 Consumer Staples 13.76%
4 Communication Services 10.53%
5 Industrials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIS icon
26
General Mills
GIS
$20.3B
$1.24B 0.96%
1,237,637
+1,207,749
+4,041% +$66.6M
ROP icon
27
Roper Technologies
ROP
$39.7B
$1.22B 0.95%
1,218,706
+1,216,556
+56,584% +$687M
VZ icon
28
Verizon
VZ
$200B
$1.17B 0.91%
1,170,756
+1,143,699
+4,227% +$49.5M
O icon
29
Realty Income
O
$61.4B
$1.13B 0.88%
1,130,884
+1,111,104
+5,617% +$62.8M
GD icon
30
General Dynamics
GD
$106B
$1.09B 0.85%
1,087,892
+1,084,162
+29,066% +$298M
NKE icon
31
Nike
NKE
$63.2B
$1.06B 0.82%
1,060,698
+1,045,567
+6,910% +$62.8M
NOC icon
32
Northrop Grumman
NOC
$77.3B
$1.04B 0.81%
1,039,958
+1,037,868
+49,659% +$510M
XBI icon
33
State Street SPDR S&P Biotech ETF
XBI
$10B
$1.02B 0.79%
1,020,039
+1,007,739
+8,193% +$80.4M
MMM icon
34
3M
MMM
$93.7B
$974M 0.76%
974,336
+967,936
+15,124% +$138M
POR icon
35
Portland General Electric
POR
$5.9B
$947M 0.74%
947,252
+923,938
+3,963% +$38.8M
CL icon
36
Colgate-Palmolive
CL
$73.5B
$859M 0.67%
859,005
+849,555
+8,990% +$77.6M
INTC icon
37
Intel
INTC
$430B
$857M 0.67%
856,934
+817,928
+2,097% +$16.9M
PAYX icon
38
Paychex
PAYX
$44B
$803M 0.62%
802,939
+797,419
+14,446% +$120M
CVS icon
39
CVS Health
CVS
$138B
$773M 0.6%
773,266
+762,056
+6,798% +$50M
PEP icon
40
PepsiCo
PEP
$197B
$763M 0.59%
763,191
+757,361
+12,991% +$102M
FLO icon
41
Flowers Foods
FLO
$1.61B
$686M 0.53%
685,542
+642,192
+1,481% +$11.1M
QCOM icon
42
Qualcomm
QCOM
$169B
$673M 0.52%
672,555
+668,332
+15,826% +$98.4M
FAST icon
43
Fastenal
FAST
$54.5B
$672M 0.52%
672,000
+656,000
+4,100% +$26.6M
META icon
44
Meta Platforms (Facebook)
META
$1.5T
$613M 0.48%
612,615
+611,785
+73,709% +$378M
T icon
45
AT&T
T
$167B
$595M 0.46%
594,746
+574,195
+2,794% +$15.8M
RTX icon
46
RTX Corp
RTX
$293B
$595M 0.46%
594,593
+590,521
+14,502% +$78.7M
AVY icon
47
Avery Dennison
AVY
$12.8B
$590M 0.46%
589,579
+586,219
+17,447% +$103M
SHEL icon
48
Shell
SHEL
$245B
$579M 0.45%
578,841
+570,605
+6,928% +$38.2M
BDX icon
49
Becton Dickinson
BDX
$46.2B
$564M 0.44%
563,774
+560,401
+16,614% +$103M
UNH icon
50
UnitedHealth
UNH
$386B
$547M 0.43%
547,195
+545,441
+31,097% +$208M

Similar funds

Broadwater Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Broadwater Capital held 227 positions worth $129B, up 100,517% from $128M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Broadwater Capital deployed $28B of net new capital in Q2 2025, opening 2 new positions and adding to 217 existing holdings. Its largest new stake was Espey Mfg & Electronics Corp: 18,284 shares worth $18.3M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the most notable exit was CNX Resources, an estimated $1.79K sold.

  • Broadwater Capital's largest Q2 2025 buy was Espey Mfg & Electronics Corp: 18,284 shares worth $18.3M.
  • Broadwater Capital added most to Microsoft in Q2 2025, an estimated $7.36B increase.
  • Broadwater Capital fully exited CNX Resources in Q2 2025, selling an estimated $1.79K.
  • Broadwater Capital's ten largest holdings make up 48% of its $129B portfolio in Q2 2025.
  • Broadwater Capital opened 2 new positions and closed 7 in Q2 2025.
  • Broadwater Capital's portfolio value rose 100,517% quarter-over-quarter to $129B.

Based on Broadwater Capital's 13F filing for Q2 2025, filed 31 Oct 2025.